HanTac:WH |
body weight gain |
bisphenol A (5 mg/kg/d) (for 14 days) |
Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. |
body mass |
female |
0 days
| 18 |
81.1 |
g |
4.9 |
20.8 |
body weighing method |
0.0 |
|
0 |
|
G7-G21 |
76273 |
1559 |
Crl:SD |
body weight gain |
controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.025 mg/l) (for 70 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
body mass |
female |
35 days-105 days |
12 |
88.3 |
g |
2.22 |
7.7 |
body weighing method |
0.0 |
|
0 |
|
week one |
75759 |
1538 |
WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 6 |
8.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101342 |
2585 |
WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
23.0 |
g |
3.0 |
6.71 |
body weighing method |
0.0 |
sham acf |
7 |
days |
change from surgery weight |
101343 |
2585 |
WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
-4.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101322 |
2585 |
WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
4.0 |
g |
1.0 |
2.65 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101326 |
2585 |
SS/Jr |
body weight gain |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
body mass |
male |
43 days-52 days |
12 |
51.0 |
g |
2.0 |
6.93 |
body weighing method |
|
|
0 |
|
|
13318 |
344 |
E3/Ztm |
body weight gain |
spinal cord homogenate (10 mg) |
Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 |
body mass |
female |
56 days-103 days |
12 |
80.0 |
g |
0.87 |
3.0 |
body weighing method |
0.0 |
|
0 |
|
|
69956 |
1258 |
BluHsd:LE |
body weight gain |
vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days) |
Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. |
body mass |
male |
71 days-98 days |
8 |
145.3 |
g |
9.3 |
26.3 |
body weighing method |
0.0 |
|
0 |
|
|
76161 |
1543 |
BluHsd:LE |
body weight gain |
controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days) |
Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. |
body mass |
male |
71 days-98 days |
8 |
150.1 |
g |
4.7 |
13.29 |
body weighing method |
0.0 |
|
0 |
|
|
76163 |
1543 |
HanTac:WH |
body weight gain |
vehicle control condition (for 14 days) |
Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. |
body mass |
female |
0 days
| 18 |
82.4 |
g |
6.22 |
26.4 |
body weighing method |
0.0 |
|
0 |
|
G7-G21 |
76270 |
1559 |
BluHsd:LE |
body weight gain |
vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days) |
Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. |
body mass |
male |
71 days-98 days |
8 |
104.6 |
g |
5.9 |
16.69 |
body weighing method |
0.0 |
|
0 |
|
|
75969 |
1543 |
WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
34.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
|
7 |
days |
change from surgery weight |
101329 |
2585 |
WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 6 |
-5.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
sham acf |
2 |
days |
change from surgery weight |
101333 |
2585 |
WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 6 |
-1.0 |
g |
1.0 |
2.45 |
body weighing method |
0.0 |
sham acf |
4 |
days |
change from surgery weight |
101337 |
2585 |
WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
3.0 |
g |
6.0 |
15.87 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101340 |
2585 |
SS/Hsd |
body weight gain |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
body mass |
male |
52 days-61 days |
0 |
61.0 |
g |
6.0 |
|
body weighing method |
0.0 |
|
0 |
|
change from surgery weight (2wks) |
103217 |
2801 |
WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
30.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
sham acf |
7 |
days |
change from surgery weight |
101327 |
2585 |
HanTac:WH |
body weight gain |
bisphenol A (0.25 mg/kg/d) (for 14 days) |
Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. |
body mass |
female |
0 days
| 17 |
82.9 |
g |
5.46 |
22.5 |
body weighing method |
0.0 |
|
0 |
|
G7-G21 |
76272 |
1559 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
body weight gain |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
body mass |
male |
43 days-52 days |
10 |
53.0 |
g |
3.0 |
9.49 |
body weighing method |
|
|
0 |
|
|
13316 |
344 |
HanTac:WH |
body weight gain |
bisphenol A (0.025 mg/kg/d) (for 14 days) |
Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. |
body mass |
female |
0 days
| 21 |
91.2 |
g |
3.06 |
14.0 |
body weighing method |
0.0 |
|
0 |
|
G7-G21 |
76271 |
1559 |
WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 6 |
8.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
sham acf |
7 |
days |
change from surgery weight |
101341 |
2585 |
WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
18.0 |
g |
1.0 |
2.24 |
body weighing method |
0.0 |
|
4 |
days |
change from surgery weight |
101325 |
2585 |
WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 8 |
-12.0 |
g |
2.0 |
5.66 |
body weighing method |
0.0 |
acf |
2 |
days |
change from surgery weight |
101332 |
2585 |
WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
-14.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
2 |
days |
change from surgery weight |
101334 |
2585 |
SR/Hsd |
body weight gain |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
body mass |
male |
52 days-61 days |
0 |
65.0 |
g |
4.0 |
|
body weighing method |
0.0 |
|
0 |
|
change from surgery weight (2wks) |
103214 |
2801 |
GK/Jpe |
body weight gain |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
body mass |
male |
450 days-540 days |
20 |
1.5 |
g |
0.7 |
3.13 |
body weighing method |
0.0 |
|
0 |
|
|
108000 |
3108 |
GK/Jpe |
body weight gain |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
body mass |
male |
450 days-540 days |
10 |
7.6 |
g |
2.6 |
8.22 |
body weighing method |
0.0 |
|
0 |
|
|
108001 |
3108 |
GK/Jpe |
body weight gain |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then soybean oil (2 ml/kg) (for 90 days) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
body mass |
male |
450 days-540 days |
10 |
50.1 |
g |
6.4 |
20.24 |
body weighing method |
0.0 |
|
0 |
|
|
108002 |
3108 |
Crl:SD |
body weight gain |
controlled fructose content drinking water (5 %) (for 70 days) and controlled ethanol content drinking water (1 %) (for 70 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
body mass |
female |
35 days-105 days |
12 |
86.2 |
g |
4.16 |
14.4 |
body weighing method |
0.0 |
|
0 |
|
week one |
75758 |
1538 |
BluHsd:LE |
body weight gain |
controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) |
Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. |
body mass |
male |
71 days-98 days |
8 |
99.5 |
g |
5.1 |
14.42 |
body weighing method |
0.0 |
|
0 |
|
|
75971 |
1543 |
BluHsd:LE |
body weight gain |
controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) |
Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. |
body mass |
male |
71 days-98 days |
8 |
103.7 |
g |
4.2 |
11.88 |
body weighing method |
0.0 |
|
0 |
|
|
75970 |
1543 |
WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
29.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
9 |
days |
change from surgery weight |
101331 |
2585 |
WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
20.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
sham acf |
4 |
days |
change from surgery weight |
101323 |
2585 |
W/Jpe |
body weight gain |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
body mass |
male |
450 days-540 days |
20 |
2.4 |
g |
0.8 |
3.58 |
body weighing method |
0.0 |
|
0 |
|
wistar |
107999 |
3108 |
SR/Hsd |
body weight gain |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
body mass |
male |
52 days-61 days |
0 |
59.0 |
g |
4.0 |
|
body weighing method |
0.0 |
|
0 |
|
change from surgery weight (2wks) |
138419 |
2801 |
E3/Ztm |
body weight gain |
spinal cord homogenate (10 mg) |
Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 |
body mass |
male |
56 days-103 days |
3 |
39.0 |
g |
5.2 |
9.0 |
body weighing method |
0.0 |
|
0 |
|
|
69957 |
1258 |
DA/Ztm |
body weight gain |
spinal cord homogenate (10 mg) |
Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 |
body mass |
male |
56 days-103 days |
9 |
32.0 |
g |
8.33 |
25.0 |
body weighing method |
0.0 |
|
0 |
|
|
69948 |
1258 |
WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
21.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
9 |
days |
change from surgery weight |
101330 |
2585 |
WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
6.0 |
g |
1.0 |
2.24 |
body weighing method |
0.0 |
sham acf |
4 |
days |
change from surgery weight |
101339 |
2585 |
LEW/Crlc |
body weight gain |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
body mass |
male |
43 days-52 days |
8 |
54.0 |
g |
3.0 |
8.49 |
body weighing method |
|
|
0 |
|
|
13315 |
344 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
body weight gain |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
body mass |
male |
43 days-52 days |
8 |
56.0 |
g |
3.0 |
8.49 |
body weighing method |
|
|
0 |
|
|
13317 |
344 |
Crl:SD |
body weight gain |
controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.25 mg/l) (for 70 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
body mass |
female |
35 days-105 days |
12 |
82.6 |
g |
2.57 |
8.9 |
body weighing method |
0.0 |
|
0 |
|
week one |
75760 |
1538 |
WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 8 |
-5.0 |
g |
2.0 |
5.66 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101336 |
2585 |
WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
-5.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101338 |
2585 |
SS/Hsd |
body weight gain |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
body mass |
male |
52 days-61 days |
0 |
58.0 |
g |
4.0 |
|
body weighing method |
0.0 |
|
0 |
|
change from surgery weight (2wks) |
103216 |
2801 |
WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 7 |
-10.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101324 |
2585 |
WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 5 |
12.0 |
g |
3.0 |
6.71 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101328 |
2585 |
GK/Jpe |
body weight gain |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then lipoic acid (50 mg/kg) (for 90 days) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
body mass |
male |
450 days-540 days |
10 |
11.9 |
g |
3.7 |
11.7 |
body weighing method |
0.0 |
|
0 |
|
|
108003 |
3108 |
BluHsd:LE |
body weight gain |
controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days) |
Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. |
body mass |
male |
71 days-98 days |
8 |
146.1 |
g |
9.1 |
25.74 |
body weighing method |
0.0 |
|
0 |
|
|
76162 |
1543 |
Crl:SD |
body weight gain |
controlled ethanol content drinking water (1 %) (for 70 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
body mass |
female |
35 days-105 days |
12 |
80.1 |
g |
2.6 |
9.0 |
body weighing method |
0.0 |
|
0 |
|
week one |
75757 |
1538 |
Crl:SD |
body weight gain |
controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (2.5 mg/l) (for 70 days) |
Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. |
body mass |
female |
35 days-105 days |
12 |
86.4 |
g |
4.01 |
13.9 |
body weighing method |
0.0 |
|
0 |
|
week one |
75761 |
1538 |
HanTac:WH |
body weight gain |
bisphenol A (50 mg/kg/d) (for 14 days) |
Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. |
body mass |
female |
0 days
| 18 |
78.8 |
g |
4.03 |
17.1 |
body weighing method |
0.0 |
|
0 |
|
G7-G21 |
76274 |
1559 |
WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
0 days
| 6 |
-6.0 |
g |
1.0 |
2.45 |
body weighing method |
0.0 |
sham acf |
2 |
days |
change from surgery weight |
101335 |
2585 |